The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cabozantinib (C) plus atezolizumab (A) or C alone in patients (pts) with advanced non–small cell lung cancer (aNSCLC) previously treated with an immune checkpoint inhibitor (ICI): Results from Cohorts 7 and 20 of the COSMIC-021 study.
 
Joel W. Neal
Honoraria - Biomedical Learning Institute; Clinical Care Options; CME Matters; Medscape; MJH Life Sciences; Peerview; Prime Oncology; Projects in Knowledge; Research to Practice; Rockpointe CME
Consulting or Advisory Role - Amgen; AstraZeneca; Blueprint Pharmaceuticals; Calithera Biosciences; D2G Oncology; Exelixis; Genentech/Roche; Iovance Biotherapeutics; Jounce Therapeutics; Lilly; Natera; Regeneron; Sanofi/Regeneron; Surface Oncology; Surface Oncology; Takeda; Turning Point Therapeutics
Research Funding - AbbVie (Inst); Adaptimmune (Inst); Boehringer Ingelheim (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Takeda (Inst)
Patents, Royalties, Other Intellectual Property - Up To Date - Royalties
 
Armando Santoro
Consulting or Advisory Role - ARQULE; Bayer; Bristol-Myers Squibb; Eisai; Gilead Sciences; Incyte; MSD; Pfizer; Sanofi; SERVIER
Speakers' Bureau - Abbvie; Amgen; ArQule; AstraZeneca; Bayer; BMS; Celgene; Eisai; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Sandoz; Servier; Takeda
 
Santiago Viteri
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Merck KGaA; Reddy Pharma Iberia; Roche; Takeda
Speakers' Bureau - Bristol-Myers Squibb; Roche
Travel, Accommodations, Expenses - MSD; OSE Immunotherapeutics; Roche
 
Santiago Ponce Aix
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Roche
Speakers' Bureau - Bristol-Myers Squibb; Merck; Roche
Travel, Accommodations, Expenses - AstraZeneca; Merck; Roche
 
Bruno Fang
Employment - Astera Cancer Care; Regional Cancer Care Associates; Regional Cancer Care Associates
Leadership - Astera Cancer Care; Regional Cancer Care Associates
Research Funding - Abbvie; Arvinas; Bristol-Myers Squibb/Pfizer; Daiichi Sankyo/Astra Zeneca; Epizyme; Exelixis; Gilead/Forty Seven; ImmunityBio; Janssen Oncology; Mirati Therapeutics; natera; Novartis; Novocure; POINT Biopharma; Roche/Genentech; Veru; Zymeworks; Zymeworks
 
Farah Louise Lim
Honoraria - Bristol-Myers Squibb; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Gerson Lehrman Group; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Roche
 
Ryan D. Gentzler
Honoraria - Targeted Oncology
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Daiichi Sankyo/Astra Zeneca; Jazz Pharmaceuticals; Mirati Therapeutics; OncoCyte; Sanofi
Research Funding - Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Helsinn Therapeutics (Inst); Janssen (Inst); Jounce Therapeutics (Inst); Merck (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); RTI International (Inst); Takeda (Inst)
 
Jerome H. Goldschmidt
Employment - Blue Ridge Cancer Care; Ontada/McKesson
Stock and Other Ownership Interests - Amgen (I)
Consulting or Advisory Role - Amgen; TG Therapeutics
Speakers' Bureau - Bristol myers squibb; G1 Therapeutics
 
Polina Khrizman
No Relationships to Disclose
 
Erminia Massarelli
Honoraria - AstraZeneca; Merck
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Daichii Sankyo Co.; Fusion Pharmaceuticals Inc.; Genentech/Roche; Janssen Scientific Affairs; Lilly; Merck; Sanofi
Speakers' Bureau - AstraZeneca; Lilly; Merck; Takeda
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Merck (Inst); Pfizer (Inst); Tessa Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Merck; Pfizer
 
Shiven B. Patel
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Regeneron; Sanofi; Tersera; Total Health Conferencing
Research Funding - AstraZeneca (Inst); Janssen (Inst); Merck (Inst); Takeda (Inst)
 
Sonam Puri
Consulting or Advisory Role - AstraZeneca (Inst); G1 Therapeutics (Inst)
 
Ramu Sudhagoni
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
 
Christian Scheffold
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
Patents, Royalties, Other Intellectual Property - Patent
 
Dominic Curran
Employment - Exelixis; Syneos Health (I)
Stock and Other Ownership Interests - Exelixis
Travel, Accommodations, Expenses - Exelixis
 
Enriqueta Felip
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol Myers Squibb; Daiichi Sankyo Europe GmbH; GlaxoSmithKline; Janssen; Lilly; Merck Serono; MSD Oncology; Novartis; Peptomyc; Pfizer; Roche; Sanofi; Takeda
Speakers' Bureau - AstraZeneca; Bristol Myers Squibb; CME outfitters; Lilly; Medscape; Merck Sharp & Dohme; PeerVoice; Pfizer; Roche; Takeda
Research Funding - Merck (Inst); Merck KGaA (Inst)
Other Relationship - GRÍFOLS